Imagine a healthcare system where a private insurer, Medicare, Medicaid, and an uninsured patient all pay hospitals the same price for the same service. In every other state, this idea would seem radical. In Maryland, it has been the operating reality for nearly five decades.

Maryland's all-payer rate setting system is the most sustained experiment in hospital payment regulation in the United States. It emerged from a 1970s political compromise and has since evolved into a global budget model that ties hospital revenue to population health rather than volume of services.

The persistent question among policy analysts is straightforward but consequential: does Maryland's approach actually work, and if so, can any of it be exported? Answering requires looking past ideology to examine what the evidence shows about costs, quality, and the political architecture that makes the system function.

Maryland's Health Services Cost Review Commission, established in 1971, sets the rates that every payer must pay for hospital services. Commercial insurers, Medicare, Medicaid, and self-pay patients all reimburse hospitals at essentially the same regulated price. This uniformity is the foundational feature that distinguishes Maryland from the rest of the country, where negotiated rates vary dramatically across payers.

The second layer, added in 2014 under a federal waiver, transformed the system into a global budget model. Each hospital receives a fixed annual revenue target, adjusted for demographics and quality performance, regardless of how many services it delivers. If a hospital admits fewer patients, its rates adjust upward to hit the budget. If it admits more, rates adjust downward.

This design fundamentally inverts hospital incentives. Under fee-for-service, more volume means more revenue. Under global budgets, additional admissions do not generate additional income, so hospitals gain financially by keeping people healthy and out of inpatient beds. The rate commission enforces this discipline through detailed reporting and revenue adjustments.

The political architecture supporting the system is equally distinctive. Maryland maintains a Medicare waiver requiring that per-capita hospital spending grow more slowly than the national average. If Maryland fails this test, the waiver could be revoked, ending the system. This external accountability creates continuous pressure that few state-level reforms possess.

Takeaway

When you change what a hospital gets paid for, you change what a hospital does. Payment design is not administrative plumbing; it is the strongest lever policymakers hold over clinical behavior.

Evaluations of Maryland's system have produced generally favorable but nuanced findings. Studies published in Health Affairs and the New England Journal of Medicine document that Maryland has met its waiver requirements, holding per-capita hospital cost growth below the national average since the global budget model launched. Cumulative Medicare savings have exceeded initial projections.

Quality indicators tell a more complicated story. Maryland has reduced hospital-acquired conditions and readmissions at rates comparable to or better than national trends. However, the state started from a higher baseline on some measures, so improvement partly reflects catching up rather than leading. Mortality outcomes and patient experience scores have moved in line with national patterns rather than diverging positively.

Utilization patterns show the clearest behavioral shift. Inpatient admissions have declined faster in Maryland than nationally, and hospitals have invested more heavily in care coordination, community health workers, and post-acute partnerships. These are the kinds of investments that make little sense under fee-for-service but rational under global budgets.

Critics note important caveats. Some cost savings may reflect shifts of care to outpatient settings not fully captured in hospital budgets. Rural hospitals have struggled under fixed budgets when local demographics shift. And the system's administrative complexity requires substantial regulatory capacity that would be difficult to replicate quickly.

Takeaway

Evidence rarely delivers verdicts as clean as advocates or critics want. The honest question is not whether a policy works, but which mechanisms work, for whom, and under what conditions.

The most common question posed to Maryland's experience is whether the model can scale. The answer depends on distinguishing what is portable from what is contextually dependent. Global budgeting as a payment mechanism is technically exportable; the political and institutional foundations that sustain it are not.

Maryland benefits from a compact geography, a relatively consolidated hospital market, and an unbroken history of rate regulation that predates most current administrators. States without these features would need to build regulatory infrastructure from scratch and confront hospital opposition without the legitimacy that decades of established practice provide.

Pennsylvania's rural hospital global budget program, launched in 2019, represents the most serious attempt to adapt elements of the Maryland approach. It applies global budgets selectively to rural hospitals rather than statewide, sidestepping the political challenge of comprehensive rate setting. Early results are promising but limited in scope, and the model depends on continued federal support through CMS demonstration authority.

A more realistic path for most states involves borrowing specific mechanisms rather than the whole system. Global budgets for financially distressed rural hospitals, all-payer claims databases to enable price transparency, and Medicare waiver structures tied to spending growth targets are individually adoptable. The comprehensive Maryland model, however, likely requires the specific political conditions that produced it in the first place.

Takeaway

Policy transfer is rarely about copying an entire system. It is about identifying which components solve which problems, and whether your context can support them.

Maryland's all-payer system is neither the utopia its advocates describe nor the aberration its skeptics dismiss. It is a functioning example of what sustained payment regulation can accomplish when political conditions permit and institutional capacity exists.

The deeper lesson is not about rate setting specifically but about the relationship between payment design and health system behavior. States that want different outcomes from their hospitals must be willing to alter what hospitals are paid to do, not merely exhort them to change.

Whether other states follow Maryland's path or borrow selectively from its toolkit, the experiment continues to offer something rare in health policy: decades of real-world evidence about what happens when incentives are genuinely realigned.